-
3 days ago | 
optometrytimes.com | Lynda Charters
Stuart Therapeutics, Inc. announced the initial results of its phase 3 clinical trial evaluating ST-100 (vezocolmitide) ophthalmic solution for treating dry eye disease. The topline results enumerated in the company’s press release are as follows:The results highlight ST-100's potential for fast-acting healing of ocular surface damage caused by dry eye disease. The therapeutic effects were observed rapidly, with relief apparent within 2 to 4 days of treatment for both signs and symptoms.
-
5 days ago | 
optometrytimes.com | Lynda Charters
The Glaucoma Foundation issued a press release that announced a major endowment gift of $2.5 million from the Herbert Simon Family Foundation. This gift will establish the Herbert Simon Chair in Glaucoma Research and Innovation. The endowment is intended to support the work of Alon Harris, MS, PhD, FARVO, an internationally renowned clinical scientist in ophthalmology and glaucoma. Elena Sturman, the Glaucoma Foundation's President and CEO, acknowledged the endowment.
-
5 days ago | 
modernretina.com | Lynda Charters
Michael A. Klufas, MD, of the retina service at Wills Eye Hospital in Philadelphia, Pennsylvania, presented 3 cases and discussed how second-generation retinal vascular agents, such as high-dose aflibercept 8 mg (Eylea HD; Regeneron Pharmaceuticals, Inc) and faricimab (Vabysmo; Genentech), show promising results for treating these 2 common disorders.
-
1 week ago | 
modernretina.com | Lynda Charters
A new study from China revealed a genetic link between coffee consumption and age-related macular degeneration (AMD). Of particular note is that instant coffee may increase the risk of development of dry AMD. Reducing its intake could help prevent dry AMD. People at high‐risk for AMD should avoid instant coffee,1 according to first author Qi Jia, MD, from theDepartment of Ophthalmology, Shiyan Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
-
1 week ago | 
optometrytimes.com | Lynda Charters
A new study from China revealed a genetic link between coffee consumption and age-related macular degeneration (AMD). Of particular note is that instant coffee may increase the risk of development of dry AMD. Reducing its intake could help prevent dry AMD. People at high‐risk for AMD should avoid instant coffee,1 according to first author Qi Jia, MD,from theDepartment of Ophthalmology, Shiyan Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
-
1 week ago | 
ophthalmologytimes.com | Lynda Charters
A recent Ophthalmology Times Case-Based Roundtable® tackled the topic of treating Demodex blepharitis and ocular surface disease (OSD) to maximize visual outcomes. Christopher E. Starr, MD, an associate professor of ophthalmology with Weill Cornell Medicine in New York, New York, described his pearls for treating affected patients. Case 1Starr described the case of a 74-year-old woman being evaluated before cataract surgery.
-
1 week ago | 
modernretina.com | Lynda Charters
Nassim Abreu, MD, reported the initial experience while applying panretinal photocoagulation (PRP) using the new LYNX pattern laser indirect ophthalmoscope (LIO) (Norlase). Abreu, who is an associate professor in the Retina Department of Elias Santana Hospital, Santo Domingo, Dominican Republic, described the technology and its performance at the Retina World Congress in Fort Lauderdale, FL. The LYNX LIO is the latest generation of pattern scanning lasers that were first introduced in 2006.
-
1 week ago | 
modernretina.com | Lynda Charters
Yasha Modi, MD, from NYU Langone Health, New York, New York, and Carl Danzig, MD, from the Rand Eye Institute, Deerfield Beach, Florida, participated in an opinion panel for Modern Retina. They discussed the clinical benefits, clinical trial results, surgical considerations, and factors affecting clinician decision-making regarding the Port Delivery System (PDS) with ranibizumab injection (Susvimo; Genentech) in clinical practice.
-
1 week ago | 
ophthalmologytimes.com | Lynda Charters
An Indonesian study of the characteristics of the retinal vasculature found that the retinal vessel tortuosity (VT) was significantly higher and the fractal dimension (FD) was significantly lower in patients with diabetic retinopathy (DR) compared with those without DR.1 Lead author Fariztah Sukainah Nur Fathimah, MD, from the Department of Ophthalmology, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia, and colleagues reported their findings in the International...
-
1 week ago | 
ophthalmologytimes.com | Lynda Charters
Nassim Abreu, MD, reported the initial experience while applying panretinal photocoagulation (PRP) using the new LYNX pattern laser indirect ophthalmoscope (LIO) (Norlase). Abreu, who is an associate professor in the Retina Department of Elias Santana Hospital, Santo Domingo, Dominican Republic, described the technology and its performance at the Retina World Congress in Fort Lauderdale, FL. The LYNX LIO is the latest generation of pattern scanning lasers that were first introduced in 2006.
